Ciprofloxacin

سیپروفلوکساسین

⚠ Unverified

🦠 Antiinfectives For Systemic UseFluoroquinolone

Market / country: 🇺🇸 USA

Cipro (US)

🧮 Dose calculator

Urinary tract infection · Regimen source: FDA Ciprofloxacin · 2.1, Table 1

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

  • ⛔ Hypersensitivity to ciprofloxacin or other quinolones; concomitant tizanidine. FDA Ciprofloxacin · 4
  • ⚠️ Boxed warning: tendinitis and tendon rupture, peripheral neuropathy, CNS effects and exacerbation of myasthenia gravis; avoid in myasthenia gravis. FDA Ciprofloxacin · Boxed Warning

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ciprofloxacin · 8.1

    “Risk Summary Prolonged experience with ciprofloxacin in pregnant women over several decades, based on available published information from case reports, case control studies and observational studies on ciprofloxacin administered during pregnancy, have not identified any drug-associated risk of major birth defects, …”
  • 🤱 BreastfeedingDangerous / avoid

    Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Ciprofloxacin · 8.2

    “Alternatively, advise a woman that breastfeeding is not recommended during treatment with ciprofloxacin and for an additional two days (five half-lives) after the last dose.”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ciprofloxacin · 8.4

    “Complicated Urinary Tract Infection and Pyelonephritis Ciprofloxacin is indicated for the treatment of cUTI and pyelonephritis due to Escherichia coli in pediatric patients 1 to 17 years of age.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ciprofloxacin · 8.5

    “Caution should be used when prescribing ciprofloxacin to elderly patients especially those on corticosteroids.”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav